Showing results (651-660 of 1,556) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|October 13, 2025
Survival Outcomes in Stage III to IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic DisparitiesShreyas Kalantri, Pranali Pachika, Tyler Jones, et al.
JCO Oncology Practice|October 11, 2025
Screened but Still Struggling: Challenges in Delivering Financial Assistance After Positive Financial Toxicity ScreensJoshua A Budhu, Amy L Tin, Melanie Steele, et al.
JCO Oncology Practice|October 13, 2025
Postimmunotherapy and Vascular Endothelial Growth Factor Inhibitor Landscape in Advanced Renal Cell Carcinoma: Treatment Patterns, Costs, and OutcomesNeil J Shah, Reshma Shinde, Rituparna Bhattacharya, et al.
JCO Oncology Practice|October 10, 2025
Leveraging Electronic Health Record Tools and Social Work to Improve Advance Care Planning Documentation in Older Adults With CancerLauren Reed-Guy, Julianne Ani, Keshav Raghavendran, et al.
JCO Oncology Practice|October 10, 2025
Financial Navigation for People Newly Diagnosed With Cancer: Primary Outcomes From the Cancer Financial Experience Randomized TrialNora B Henrikson, Melissa L Anderson, John Dickerson, et al.
JCO Oncology Practice|October 10, 2025
Colorectal Cancer Legal and Administrative Burden Support (COLLABS): A Pilot Clinical TrialQuan Phung, Kendall Lin, Rick J Jansen, et al.
JCO Oncology Practice|September 24, 2025
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer SurvivorsShakirah N Ssebyala, Yue Zheng, Elizabeth Riley, et al.
JCO Oncology Practice|July 17, 2025
Implementation of Quality Improvement Interventions in Medical Oncology: A Systematic ReviewGeorgia Zachou, Sukumar S Sugeeta, Joanna Dodkins, et al.
JCO Oncology Practice|August 1, 2025
Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled TrialAreen Khateeb Alabbasi, Manfred S Green, Shuli Brammli-Greenberg, et al.
JCO Oncology Practice|June 3, 2025
Use of Ablative Radiotherapy in the Setting of Oligometastatic DiseaseFady Sourial, Chirag Shah, Paul Renz
Pageof 156